Filter
234
Filtered Results: 234
Text search:
vaccine
vial
monitor
Featured
Recommendations
40
New Publications
75
Language
Document type
No document type
107
Guidelines
70
Manuals
22
Studies & Reports
13
Fact sheets
10
Strategic & Response Plan
8
Training Material
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
18
South Africa
11
Kenya
10
Uganda
10
Tanzania
6
Philippines
5
Global
5
Ethiopia
5
Nepal
4
Rwanda
4
Nigeria
4
Africa
4
Argentina
4
Zimbabwe
3
Latin America and the Carribbean
3
Liberia
3
Sierra Leone
2
Senegal
2
West and Central Africa
2
Bangladesh
2
Zambia
2
Myanmar / Burma
2
Cameroon
1
Syria
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Paraguay
1
United Kingdom
1
Brazil
1
Russia
1
Namibia
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Botswana
1
South Sudan
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
94
Clinical Guidelines
39
Women & Child Health
20
Public Health
13
Key Resources
9
Capacity Building
4
Pharmacy & Technologies
4
Toolboxes
COVID-19
48
Pharmacy
25
Rapid Response
16
AMR
9
Ebola & Marburg
8
Polio
8
HIV
6
TB
5
Caregiver
4
NTDs
3
Natural Hazards
2
Cholera
2
NCDs
2
Conflict
2
Mental Health
1
Refugee
1
Planetary Health
1
Zika
1
Interim Guidance, published 11 January 2021.
The cold chain is necessary to prevent damage to vaccines caused by heat exposure. However, improper use of cold chain equipment may cause damage to freeze-sensitive vaccines (i.e. those vaccines containing alum adjuvant or oil-emulsion adjuvant). Studie...
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.
This document has been updated: 31 August 2021
WHO Vaccine Management Handbook
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc...
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
A handbook for district and health facility staff
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
A handbook for district and health facility staff
Accessed December 2017
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Accessed Sept, 5 2018
Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
